C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/1997
12/04/1997	WO1997045544A1 Antibodies to the ed-b domain of fibronectin, their construction and uses
12/04/1997	WO1997045451A1 Anti-human lect2 antibody, cells producing the same, and method and kit for assaying the same
12/04/1997	WO1997045450A1 Anti-endoglin monoclonal antibodies and their use in antiangiogenic therapy
12/04/1997	WO1997045447A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF αvβ5 MEDIATED ANGIOGENESIS
12/04/1997	WO1997045445A1 Protein markers for esophageal cancer
12/04/1997	WO1997045143A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
12/04/1997	WO1997045140A1 Concentrated antibody preparation
12/04/1997	WO1997045137A1 Methods and compositions useful for inhibition of angiogenesis
12/04/1997	WO1997045128A1 Apoptosis associated protein bbk
12/04/1997	WO1997045106A1 Identification of genes altered in multiple myeloma
12/04/1997	WO1997041206A3 Von willebrand factor multimerase
12/04/1997	WO1997040134A3 Human dnase ii
12/04/1997	WO1997038293A3 Assays and reagents for identifying anti-fungal agents, and uses related thereto
12/04/1997	CA2256588A1 Methods and compositions useful for inhibition of .alpha.v.beta.5 mediated angiogenesis
12/04/1997	CA2256481A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
12/04/1997	CA2256455A1 Identification of genes altered in multiple myeloma
12/04/1997	CA2256372A1 Apoptosis associated protein bbk
12/04/1997	CA2256310A1 Melanoma and prostate cancer specific antibodies for immunodetection and immunotherapy
12/04/1997	CA2254983A1 Concentrated antibody preparation
12/03/1997	EP0810435A2 Detectable molecules, method of preparation and use
12/03/1997	EP0810285A2 Mutants of human Interleukin-3
12/03/1997	EP0810230A2 Anti-HIV antibodies used as control probes
12/03/1997	EP0809806A1 Monoclonal antibodies for human osteogenic cell surface antigens
12/03/1997	EP0809701A1 Calcineurin regulatable adenylate cyclase
12/03/1997	EP0809699A1 New chemokines expressed in pancreas
12/03/1997	EP0809697A2 Human peroxisome proliferator activated receptors gamma
12/03/1997	EP0809695A1 Transcription factor - e2f-5
12/03/1997	EP0809656A1 MONOCLONAL ANTIBODY SPECIFIC FOR $g(b)A4 PEPTIDE
12/03/1997	EP0809648A1 Neuropeptide y receptor
12/03/1997	EP0809517A1 Anti-transforming growth factor-beta gene therapy
12/03/1997	EP0809510A1 LYMPHOTOXIN-$g(a)/$g(b) COMPLEXES AND ANTI-LYMPHOTOXIN-BETA RECEPTOR ANTIBODIES AS ANTI-TUMOR AGENTS
12/03/1997	EP0809500A1 Novel glucocorticoid response elements
12/03/1997	EP0627939B1 Conjugates of biotin and deferoxamine for radioimmunoimaging and radioimmunotherapy
12/03/1997	EP0533838B1 Nucleic acid ligands
12/03/1997	CN1166838A Antibodies against allogenic and Xenogenic proteins, their use in diagnosis and therapy and methods for determination thereof
12/03/1997	CN1166837A Chromosome 21 gene marker, compositions and methods using same
12/02/1997	US5693780 Recombinant antibodies for human therapy
12/02/1997	US5693778 Purified dna molecule having specified nucleotide sequence
12/02/1997	US5693776 Nucleic acids specific for Rochalimaea quintana
12/02/1997	US5693775 Fibroblast growth factor homologous factor-1 (FHF-1) and methods of use
12/02/1997	US5693764 Nucleotide or nucleoside photoaffinity compound modified antibodies, methods for their manufacture and use thereof as diagnostics and therapeutics
12/02/1997	US5693763 Antibodies to human carcinoma antigen
12/02/1997	US5693762 Humanized immunoglobulins
12/02/1997	US5693761 Genetic engineering; complementarity zones
12/02/1997	US5693758 Polypeptide competitor specific for immunoglobulin e low affinity receptor sites
12/02/1997	US5693757 Huntingtin DNA, protein and uses thereof
12/02/1997	US5693753 Method of isolating βA4 peptide species ending at carboxy-terminals residue 42 using monoclonal antibody 369.2B
12/02/1997	US5693752 Hexapeptides of specified amino acid sequences
12/02/1997	US5693658 Hapten conjugates used to determine the presence and concentration of other imidazolinone compounds
12/02/1997	US5693536 Introducing wild-type mutated colorectal cancer gene into cell which has lost this function, then gene expression for antitumor activity
12/02/1997	US5693516 Mixing with a surfactant and a water immiscible organic solvent to form a reverse micelle solution; evaporation to dryness
12/02/1997	US5693500 Using a dna probe corresponding to all or a portion of the m. bovis dna antigen; test kits; sensitivity
12/02/1997	US5693495 Allergens of alder pollen and applications thereof
12/02/1997	US5693493 Modular assembly of antibody genes, antibodies prepared thereby and use
12/02/1997	US5693492 Purified dna molecule encoding drosophila avermectin and/or glutamate binding protein which functions as glutamate-gated anion channel
12/02/1997	US5693491 Isolated and purified polynucleotide comprising nucleotide sequence encoding receptor having specified amino acid sequence
12/02/1997	US5693486 Microbiocides against escherichia, listeria, candida; contact lens antiseptic
12/02/1997	US5693482 Neural chest stem cell assay
12/02/1997	US5693478 Method of detecting amyloid precursor proteins
12/02/1997	US5693477 Receptor membranes
12/02/1997	US5693472 Detecting dna of seq id no:1,2,3 or 4 by hybridization probing and/or nucleotide sequence amplification; testing samples of surface water or feces; vaccines
12/02/1997	US5693323 Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
12/02/1997	US5693322 Using antibodies that can cross-associate with antibodies on other cells to bring the cells into proximity with one another
11/1997
11/29/1997	CA2187728A1 Iron-regulated metal transporters and uses therefor
11/27/1997	WO1997044668A1 Early detection of lysosomal storage disorders
11/27/1997	WO1997044493A1 Anti-paramyxovirus screening method and vaccine
11/27/1997	WO1997044468A1 HUMAN INTERLEUKIN-1j AND ANTAGONISTS THEREOF
11/27/1997	WO1997044467A1 MITOGEN-ACTIVATED PROTEIN KINASE p38-2 AND METHODS OF USE THEREFOR
11/27/1997	WO1997044466A1 Characterization and use of an isolated uridine diphospho-glucuronosyltransferase
11/27/1997	WO1997044461A2 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
11/27/1997	WO1997044460A1 Modulators of tissue regeneration
11/27/1997	WO1997044458A1 Kappa/mu-like protein tyrosine phosphatase, ptp lambda
11/27/1997	WO1997044457A1 Polycystic kidney disease gene
11/27/1997	WO1997044454A2 Human phospholipase inhibitor
11/27/1997	WO1997044453A1 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
11/27/1997	WO1997044452A1 Human b-cell antigens, related reagents
11/27/1997	WO1997044445A1 Cross-linked protein crystal formulations and their use as catalysts in organic solvents
11/27/1997	WO1997044441A1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines
11/27/1997	WO1997044362A1 MUTATED NONACTIVATING IgG2 DOMAINS AND ANTI-CD3 ANTIBODIES INCORPORATING THE SAME
11/27/1997	WO1997044361A1 Endoglucanases
11/27/1997	WO1997044360A1 Novel human g-protein coupled receptor
11/27/1997	WO1997044359A1 Novel human g-protein coupled receptor
11/27/1997	WO1997044356A2 RET LIGAND (RetL) FOR STIMULATING NEURAL AND RENAL GROWTH
11/27/1997	WO1997044352A1 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof
11/27/1997	WO1997044060A1 Passively administered antibody that enhances feed conversion efficiency
11/27/1997	WO1997044059A2 Cartilage type ii collagen as an angiogenic factor
11/27/1997	WO1997044052A1 Immunomodulating compounds comprising d-isomers of amino acids
11/27/1997	WO1997044000A2 Dna-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents
11/27/1997	WO1997035976A3 Epidermal differentiation factor
11/27/1997	WO1997024974A3 Compositions and methods for diagnosis of mutation in the von hippel-lindau tumor suppressor gene
11/27/1997	DE19629938C1 Monoclonal antibodies specific for mutated E-Cadherin peptide sequences
11/27/1997	DE19620804A1 Cassette for expressing storage-stable proteins in plants
11/27/1997	CA2804657A1 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
11/27/1997	CA2731490A1 Early detection of lysosomal storage disorders
11/27/1997	CA2496906A1 Ret ligand (retl) for stimulating neural and renal growth
11/27/1997	CA2258698A1 Immunomodulating compounds comprising d-isomers of amino acids
11/27/1997	CA2256302A1 Endoglucanases
11/27/1997	CA2255906A1 Human interleukin-1j and antagonists thereof
11/27/1997	CA2255888A1 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof
11/27/1997	CA2255712A1 Characterization and use of an isolated uridine diphospho-glucuronosyltransferase

1 ... 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 ... 1494